Cost-Effectiveness Analysis of Pembrolizumab for Bacillus Calmette-Guérin-Unresponsive Carcinoma in Situ of the Bladder

Kevin M. Wymer, Vidit Sharma, Christopher S. Saigal, Karim Chamie, Mark S. Litwin, Vignesh T. Packiam, Matthew Mossanen, Lance C. Pagliaro, Bijan J. Borah, Stephen A. Boorjian

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Cost-Effectiveness Analysis of Pembrolizumab for Bacillus Calmette-Guérin-Unresponsive Carcinoma in Situ of the Bladder'. Together they form a unique fingerprint.

Medicine & Life Sciences